The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Latkin Jed since year 2005.
The trader's CIK number is 1554593.
At the time of the last reporting, Latkin Jed was the CEO, COO & CFO of Navidea Biopharmaceuticals, Inc. .
(stock ticker symbol NAVB).
See this page for all insider trading activities at Navidea Biopharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-06-05||NAVB||Navidea Biopharmaceuticals, Inc.||Buy||1,000||1.26||1,258|
|2019-05-17||NAVB||Navidea Biopharmaceuticals, Inc.||Buy||1,000||1.46||1,463|
|2019-05-16||NAVB||Navidea Biopharmaceuticals, Inc.||Buy||1,500||1.45||2,181|
|2019-05-15||NAVB||Navidea Biopharmaceuticals, Inc.||Buy||1,000||1.45||1,448|
|2019-05-14||NAVB||Navidea Biopharmaceuticals, Inc.||Buy||2,000||1.84||3,680|
|2019-05-13||NAVB||Navidea Biopharmaceuticals, Inc.||Buy||2,400||1.91||4,593|
|2017-05-30||NAVB||Navidea Biopharmaceuticals, Inc.||Buy||7,600||.44||3,313|
|2017-05-22||NAVB||Navidea Biopharmaceuticals, Inc.||Buy||11,200||.45||5,040|
|2017-05-19||NAVB||Navidea Biopharmaceuticals, Inc.||Buy||14,159||.45||6,385|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Latkin Jed (CEO, COO & CFO of Navidea Biopharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.